{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:01Z","timestamp":1792788001324,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Korea Health Industry Development Institute","award":["HI22C0667"],"award-info":[{"award-number":["HI22C0667"]}],"id":[{"id":"https:\/\/ror.org\/00fdzyk40","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-026-05469-1","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:45:04Z","timestamp":1784526304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations of Ginkgo biloba extract exposure with 12-month cognitive trajectories in amyloid PET\u2013positive mild cognitive impairment and Alzheimer\u2019s disease: a pooled retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"YoungSoon","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Tae","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"5469_CR1","doi-asserted-by":"crossref","unstructured":"Cummings J, Lee G, Nahed P et al. Alzheimer\u2019s disease drug development pipeline: 2022. Alzheimers Dement (N Y). 2022;8:e12295.","DOI":"10.1002\/trc2.12295"},{"key":"5469_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1006\/jmcc.1996.0316","volume":"29","author":"S Pietri","year":"1997","unstructured":"Pietri S, Maurelli E, Drieu K, et al. Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761). J Mol Cell Cardiol. 1997;29:733\u201342.","journal-title":"J Mol Cell Cardiol"},{"key":"5469_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/alz.12683","volume":"19","author":"T Ashleigh","year":"2023","unstructured":"Ashleigh T, Swerdlow RH, Beal MF. The role of mitochondrial dysfunction in Alzheimer\u2019s disease pathogenesis. Alzheimers Dement. 2023;19:333\u201342.","journal-title":"Alzheimers Dement"},{"key":"5469_CR4","first-page":"8288818","volume":"2022","author":"N-E-T Das","year":"2022","unstructured":"Das N-E-T, Lami R. Ginkgo biloba: A Treasure of Functional Phytochemicals with Multimedicinal Applications. Evid Based Complement Alternat Med. 2022;2022:8288818.","journal-title":"Evid Based Complement Alternat Med"},{"key":"5469_CR5","first-page":"CD003120","volume":"2","author":"J Birks","year":"2007","unstructured":"Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2007;2:CD003120.","journal-title":"Cochrane Database Syst Rev"},{"key":"5469_CR6","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1001\/jama.2008.683","volume":"300","author":"ST DeKosky","year":"2008","unstructured":"DeKosky ST, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for the prevention of dementia: a randomized controlled trial. JAMA. 2008;300:2253\u201362.","journal-title":"JAMA"},{"key":"5469_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S1474-4422(12)70206-5","volume":"11","author":"B Vellas","year":"2012","unstructured":"Vellas B, Coley N, Ousset PJ, et al. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer\u2019s disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol. 2012;11:851\u20139.","journal-title":"Lancet Neurol"},{"key":"5469_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/cns.13095","volume":"25","author":"N Kandiah","year":"2019","unstructured":"Kandiah N, Ong PA, Yuda T, et al. Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: expert consensus on the use of Ginkgo biloba extract EGb 761. CNS Neurosci Ther. 2019;25:288\u201398.","journal-title":"CNS Neurosci Ther"},{"key":"5469_CR9","doi-asserted-by":"publisher","first-page":"1240655","DOI":"10.3389\/fneur.2023.1240655","volume":"14","author":"A \u00d6zge","year":"2023","unstructured":"\u00d6zge A, Ghouri R, \u00d6ks\u00fcz N, et al. Early intervention and adding effective doses of EGb 761-like Ginkgo extract slow down dementia progression: insights to the neurovascular unit. Front Neurol. 2023;14:1240655.","journal-title":"Front Neurol"},{"key":"5469_CR10","doi-asserted-by":"publisher","first-page":"e12338","DOI":"10.1002\/trc2.12338","volume":"8","author":"JM Garc\u00eda-Alberca","year":"2022","unstructured":"Garc\u00eda-Alberca JM, Gris E, Mendoza S. Combined treatment with Ginkgo biloba extract EGb 761 plus acetylcholinesterase inhibitors improved cognitive function and neuropsychiatric symptoms in patients with mild cognitive impairment. Alzheimers Dement (N Y). 2022;8:e12338.","journal-title":"Alzheimers Dement (N Y)"},{"key":"5469_CR11","doi-asserted-by":"publisher","first-page":"1563056","DOI":"10.3389\/fneur.2025.1563056","volume":"16","author":"Y Yang","year":"2025","unstructured":"Yang Y, Koo MS, Kwak YT. Efficacy of Ginkgo biloba as an adjunct to donepezil in amyloid PET-positive Alzheimer\u2019s patients. Front Neurol. 2025;16:1563056.","journal-title":"Front Neurol"},{"key":"5469_CR12","doi-asserted-by":"publisher","first-page":"1639924","DOI":"10.3389\/fneur.2025.1639924","volume":"16","author":"Y Yang","year":"2025","unstructured":"Yang Y, Koo MS, Kwak YT. Efficacy of Ginkgo biloba extract in amyloid PET-positive patients with mild cognitive impairment. Front Neurol. 2025;16:1639924.","journal-title":"Front Neurol"},{"key":"5469_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13195-017-0310-6","volume":"9","author":"SSA An","year":"2017","unstructured":"An SSA, Lee BS, Yu JS, et al. Dynamic changes of oligomeric amyloid \u03b2 levels in plasma induced by spiked synthetic A\u03b242. Alzheimers Res Ther. 2017;9:86.","journal-title":"Alzheimers Res Ther"},{"key":"5469_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13195-017-0324-0","volume":"9","author":"MJ Wang","year":"2017","unstructured":"Wang MJ, Yi S, Han JY, et al. Oligomeric forms of amyloid-\u03b2 protein in plasma as a potential blood-based biomarker for Alzheimer\u2019s disease. Alzheimers Res Ther. 2017;9:98.","journal-title":"Alzheimers Res Ther"},{"key":"5469_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109\u201338.","journal-title":"Annu Rev Clin Psychol"},{"key":"5469_CR16","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1002\/alz.13770","volume":"20","author":"RT Muir","year":"2024","unstructured":"Muir RT, Hill MD, Black SE, et al. Minimal clinically important difference in Alzheimer\u2019s disease: rapid review. Alzheimers Dement. 2024;20:3352\u201363.","journal-title":"Alzheimers Dement"},{"key":"5469_CR17","unstructured":"US Food and Drug Administration. Peripheral and Central Nervous System Drugs Advisory Committee Meeting Materials. 2023. Available from: https:\/\/www.fda.gov\/media\/169263\/download. Accessed 4 Jun 2025."},{"key":"5469_CR18","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group. Neurology. 1984;34:939\u201344.","journal-title":"Neurology"},{"key":"5469_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol. 1999;56:303\u20138.","journal-title":"Arch Neurol"},{"key":"5469_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.12779\/dnd.2018.17.1.11","volume":"17","author":"J Chin","year":"2018","unstructured":"Chin J, Park J, Yang SJ, et al. Re-standardization of the Korean Instrumental Activities of Daily Living (K-IADL): clinical usefulness for various neurodegenerative diseases. Dement Neurocogn Disord. 2018;17:11\u201322.","journal-title":"Dement Neurocogn Disord"},{"key":"5469_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3233\/JAD-2003-5404","volume":"5","author":"JV Smith","year":"2003","unstructured":"Smith JV, Luo Y. Elevation of oxidative free radicals in Alzheimer\u2019s disease models can be attenuated by Ginkgo biloba extract EGb 761. J Alzheimers Dis. 2003;5:287\u2013300.","journal-title":"J Alzheimers Dis"},{"key":"5469_CR22","doi-asserted-by":"publisher","first-page":"12197","DOI":"10.1073\/pnas.182425199","volume":"99","author":"Y Luo","year":"2002","unstructured":"Luo Y, Smith JV, Paramasivam V, et al. Inhibition of amyloid-\u03b2 aggregation and caspase-3 activation by the Ginkgo biloba extract EGb 761. Proc Natl Acad Sci U S A. 2002;99:12197\u2013202.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5469_CR23","doi-asserted-by":"publisher","first-page":"915691","DOI":"10.1155\/2013\/915691","volume":"2013","author":"N Brondino","year":"2013","unstructured":"Brondino N, De Silvestri A, Re S, et al. A systematic review and meta-analysis of Ginkgo biloba in neuropsychiatric disorders: from ancient tradition to modern-day medicine. Evid Based Complement Alternat Med. 2013;2013:915691.","journal-title":"Evid Based Complement Alternat Med"},{"key":"5469_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12911-022-02024-z","volume":"22","author":"YC Youn","year":"2022","unstructured":"Youn YC, Kim HR, Shin HW, et al. Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-\u03b2 oligomerization data. BMC Med Inf Decis Mak. 2022;22:286.","journal-title":"BMC Med Inf Decis Mak"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-026-05469-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05469-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05469-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:09:37Z","timestamp":1791986977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-026-05469-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5469"],"URL":"https:\/\/doi.org\/10.1186\/s12906-026-05469-1","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of Soonchunhyang University Cheonan Hospital (IRB No. 2023-02-038-002). The study was conducted in accordance with the Declaration of Helsinki. Due to the retrospective nature of the study and the use of de-identified registry data, the requirement for written informed consent was waived by the Institutional Review Board.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"299"}}